Telomir Pharmaceuticals, Inc. (NASDAQ: TELO)
$4.4550
+0.1550 ( +4.09% ) 98.0K
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.
Market Data
Open
$4.4550
Previous close
$4.3000
Volume
98.0K
Market cap
$131.51M
Day range
$4.1000 - $4.4550
52 week range
$3.1100 - $20.7200
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Dec 23, 2024 |
| 8-k | 8K-related | 15 | Dec 20, 2024 |
| 8-k | 8K-related | 13 | Dec 11, 2024 |
| 8-k | 8K-related | 13 | Dec 02, 2024 |
| 4 | Insider transactions | 1 | Nov 25, 2024 |
| 8-k | 8K-related | 13 | Nov 21, 2024 |
| 8-k | 8K-related | 13 | Nov 20, 2024 |
| 10-q | Quarterly Reports | 41 | Nov 12, 2024 |
| 8-k | 8K-related | 14 | Sep 27, 2024 |
| 4 | Insider transactions | 1 | Sep 04, 2024 |